Recombinant Cynomolgus CD25/IL-2R alpha Fc Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 10721-RL
Key Product Details
Source
HEK293
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived cynomolgus monkey CD25/IL-2R alpha protein
Cynomolgus Monkey CD25/IL-2R alpha (Glu22-Arg213) Accession # NP_001270633.1 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Glu22
Predicted Molecular Mass
48 kDa
SDS-PAGE
64-73 kDa, under reducing conditions
Activity
Measured by its ability to inhibit the IL-2-dependent proliferation of MO7e human megakaryocytic leukemic cells.
The ED50 for this effect is 0.40-3.20 μg/mL.
The ED50 for this effect is 0.40-3.20 μg/mL.
Scientific Data Images for Recombinant Cynomolgus CD25/IL-2R alpha Fc Protein, CF
Recombinant Cynomolgus Monkey CD25/IL-2R alpha Fc Chimera Protein Bioactivity.
Recombinant Cynomolgus Monkey CD25/IL-2R alpha Fc Chimera (Catalog # 10721-RL) inhibits the IL-2-dependent proliferation of MO7e human megakaryocytic leukemic cells. The ED50 for this effect is 0.40-3.20 μg/mL.Recombinant Cynomolgus Monkey CD25/IL-2R alpha Fc Chimera Protein SDS-PAGE.
2 μg/lane of Recombinant Cynomolgus Monkey CD25/IL-2R alpha Fc Chimera (Catalog # 10721-RL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 64-73 kDa and 128-146 kDa, respectively.Formulation, Preparation and Storage
10721-RL
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: CD25/IL-2R alpha
References
- Minami, Y. et al. (1993) Annu. Rev. Immunol. 11:245.
- Kovanen, P.E. and Leonard, W.J. (2004) Immunol. Rev. 202:67.
- Bluestone, J.A. and Tang, Q. (2005) Curr. Opin. Immunol. 17:638.
- Hatakeyama, M. et al. (1989) Science 244:551.
- Takeshita, T. et al. (1992) Science 257:379.
- Stauber, D. et al. (2006) Proc. Natl. Acad. Sci. U.S.A. 103:2788.
- Wang, X. et al. (2005) Science 310:1159.
- Wagner, D.K. et al. (1986) J. Immunol. 137:592.
- Schulz, O. et al. (1998) J. Exp. Med. 187:271.
- Witkowska, A.M. (2005) Mediat. Inflamm. 2005:121.
- Willerford, D.M. et al. (1995) Immunity 3:521.
- Van Parijs, L. et al. (1997) J. Immunol. 158:3738.
- Almeida, A.R.M. et al. (2002) J. Immunol. 169:4850.
- Zammarchi, F. et al. (2020) J. Immunother Cancer. 8:e000860.
- Maruoka, A.F. et al. (2020) J. Immunol. Res. 8:345.
Long Name
Interleukin 2 Receptor alpha
Alternate Names
CD25, IL-2 R alpha, IL-2Ra, IL2R alpha, IL2RA
Entrez Gene IDs
Gene Symbol
IL2RA
UniProt
Additional CD25/IL-2R alpha Products
Product Documents for Recombinant Cynomolgus CD25/IL-2R alpha Fc Protein, CF
Product Specific Notices for Recombinant Cynomolgus CD25/IL-2R alpha Fc Protein, CF
For research use only
Loading...
Loading...
Loading...
Loading...